// App-Quantinova.ai

PO0894 : Targeting αvβ8 Integrin Improves Renal Function Through Local Inhibition of TGF-β Activation

Researchers

Presenter

  • Liarte Marin Elena

Principal Investigators

  • Liang Lihuan

  • Seth Asha

  • Heasman StephanieC

  • Selvarajah Viknesh

  • MacPhee Iain

  • Wang Xiaozhen

  • Hartleib-Geschwindner Judith

  • Moreno Quinn CarolPatricia

  • Baker DavidJ

  • Feliers Denis

Medical Centers

  • Renal Bioscience Research and Early Development Cardiovascular Renal and Metabolism (CVRM) BioPharmaceuticals R&D AstraZeneca Cambridge United Kingdom

  • Imaging & Artificial Intelligence Clinical Pharmacology & Safety Sciences BioPharmaceuticals R&D AstraZeneca Cambridge United Kingdom

  • Renal Bioscience Research and Early Development Cardiovascular Renal and Metabolism (CVRM) BioPharmaceuticals R&D AstraZeneca Cambridge United Kingdom

  • Renal Bioscience Research and Early Development Cardiovascular Renal and Metabolism (CVRM) BioPharmaceuticals R&D AstraZeneca Cambridge United Kingdom

Locations

  • United Kingdom

  • United States

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Lysosomal acid phosphatase

  • Transforming growth factor beta

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved